Select Page

Blog | International platform for Entrepreneurs & Investors

Washington D.C. Biotechnology & Life Sciences Startups: 2024 Ecosystem Funding, Innovation, and Clinical Growth

Washington D.C. Biotechnology & Life Sciences Startups: 2024 Ecosystem Funding, Innovation, and Clinical Growth

In 2024, Washington D.C.’s biotech and life sciences startups secured major funding rounds, with the region’s firms raising nearly $5.4 billion in VC from 2019 to 2024. The nation’s capital now ranks 11th globally for venture-backed life science innovation, powered by new clinical-stage breakthroughs, digital health, and a robust research infrastructure.

Fund Administration & Operations in Ireland: Growth, Innovation, and Regulatory Resilience

Fund Administration & Operations in Ireland: Growth, Innovation, and Regulatory Resilience

Assets under administration in Irish-domiciled funds reached €5.8 trillion in early 2026, underlining Ireland’s status as Europe’s leading ETF domicile and a global powerhouse for UCITS, ICAVs, and private market structures. This surge is powered by robust fund administration, operational expertise, and a sophisticated regulatory environment. Explore the evolving landscape of fund administration, middle office innovation, and regulatory priorities shaping Ireland’s fund industry. For more global fund insights, see the Damalion blog.

Categories

Details about how we process your information are available in our Privacy Policy.
Menu